
UAE Left Ventricular Assist Devices (LVADs) Market Research Report Forecast: (2025-2030)
UAE Left Ventricular Assist Devices (LVADs) Market - By Type of Flow (Pulsatile Flow, Non-Pulsatile Flow), By Design (Implantable Ventricular Assist Devices, Transcutaneous Ventric...ular Assist Devices), By Application (Bridge to Transplantation, Destination Therapy, Bridge to Recovery, Bridge to Candidacy) and Others Read more
- Healthcare
- Jan 2025
- 121
- PDF, Excel, PPT
Market Definition
A surgically implanted pump is a left ventricular assist device or LVAD, aiding the pumping of blood from the left lower chamber in the heart. Pumping oxygen-rich blood into the aorta and eventually to all the other organs is done by the left ventricle assisted through the device in case of heart disease.
Market Insights & Analysis: UAE Left Ventricular Assist Devices (LVADs) Market (2025-30):
The UAE Left Ventricular Assist Devices (LVADs) Market size was valued at around USD 391.29 million in 2024 and is projected to reach USD 511.22 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 4.45% during the forecast period, i.e., 2025-30. Numerous significant factors are driving the market for left ventricular assist devices in the United Arab Emirates. The various healthcare initiatives started by the UAE government with the goal of improving cardiovascular care and creating an environment that is favorable for the use of LVAD are a major source of motivation.
Report Coverage | Details |
---|---|
Historical Years | 2020-23 |
Base Years
|
2024
|
Forecast Years
|
2025-30
|
Market Value in 2024 | USD 391.29 Million |
Market Value in 2030 | USD 511.22 Million |
CAGR (2025-30) | 4.45% |
Top Key Players | Abbott Laboratories, Cadrenal Therapeutics, Fresenius Medical Care AG & Co. KgaA, Abiomed Inc., Teleflex Incorporated, SynCardia Systems, CardiacAssist, Inc., Jarvik 2000, Reliant Heart, Edwards Lifesciences, GE Healthcare, and others |
Key Report Highlights |
|
*Boost strategic growth with in-depth market analysis - Get a free sample preview today!
To fight against cardiovascular diseases, the UAE's Ministry of Health and Prevention started an initiative to identify research priorities. Additionally, advancements in LVAD technology have increased their use by making them simpler to implant, more compact, and more efficient. Moreover, growing public and healthcare professional knowledge of heart disease and LVAD technology has improved market acceptability especially as heart disease awareness campaigns proliferate. Moreover, as heart failure cases rise, LVADs are becoming critical in stabilizing patients awaiting heart transplants. With a strong focus on improving healthcare access and quality, the private healthcare sector is increasingly adopting LVADs, expanding market access.
Furthermore, the pediatric LVAD market in the UAE is an untapped opportunity, with few solutions available for younger patients suffering from severe heart failure. As research and development efforts intensify, innovations in LVAD technology are expected to improve patient outcomes and drive market growth. Telemedicine and remote monitoring for LVAD patients is another promising opportunity to improve post-implant care and reduce hospital readmissions. Moreover, the trend toward less invasive LVAD techniques is significant because they are less risky and require less recovery time. This trend will continue as continuous-flow LVADs become more popular because of their effectiveness compactness and reduced complications. To guarantee better care of patients on LVAD, hospitals in the United Arab Emirates are also using cutting-edge technologies like remote monitoring more frequently. The growing call for LVADs, in which patient-centric care for transplantation could improve survival rate, also forced LVAD to be customized to meet the needs of the patients. Thus, all these reasons add up to the UAE LVAD being one of the fastest-growing markets in the region offering new solutions and better access to healthcare services for an increasingly busy population.

UAE Left Ventricular Assist Devices Market Driver:
Increasing Prevalence of Heart Failure in the UAE – Increasing heart failure rate is the primary factor driving the growth of the left ventricular assist device market in the United Arab Emirates. Coronary heart disease leads to maximum deaths in UAE with 40% of all fatalities attributed to cardiovascular diseases in this country as per the Ministry of Health and Prevention. Since Heart failure is common in the aged population, hence modern treatments like LVADs are required. By the end of 2050, there is a probability of 2 million people in the United Arab Emirates to be 60 years of age or older. It is expected that this demographic shift will similarly increase demand for LVADs as heart failure will become more frequent in older adults. Similarly contributing to the rising prevalence of coronary heart failure are lifestyle factors including obesity rates that surpass 28% and the roughly 50% of individuals being overweight. The need for LVADs is similarly increased by a sedentary lifestyle that increases heart-related troubles.
UAE Left Ventricular Assist Devices Market Growth Opportunity:
Growing Healthcare Infrastructure – The UAE's expanding healthcare system offers the LVAD market a sizable opportunity. To offer top-notch healthcare services, the UAE government has made significant investments in this field. UAE's healthcare system will reach up to USD 34 billion in FY24 and expand at a compound annual growth rate of about 8% over the following five years. Hospitals and specialized cardiac facilities like the Cleveland Clinic Abu Dhabi and the Dubai Heart Center which can provide LVAD therapy among others have been developed as a result of it. By 2022, in Dubai alone, the number of private medical facilities reached 4,482, including 56 hospitals, and 55,208 licensed medical professionals. Additionally, in 2023, Dubai was ranked as the no. 1 medical tourism in the MENA region and sixth globally as per the Medical Tourism Index. This is driving demand for high-quality cardiac care, with over 674,000 medical tourists visiting in the year 2023, many seeking specialized heart failure treatments. With continuous improvements in healthcare facilities and medical technology, the UAE is increasingly positioned as a leader in cardiac care, creating ample opportunities for LVAD adoption and market expansion.
UAE Left Ventricular Assist Devices Market Challenge:
High Cost Associated with the Use of LVAD – One of the major obstacles in the UAE LVAD market is the high price. A huge amount is needed for a complicated procedure of implantation of the LVAD which includes both the cost of the device itself and also the cost of surgery with aftercare. The device alone could cost between USD 70,000 and 175,000. The entire cost including surgery, hospitalization, and post-operative care can surpass USD 200,000. These expenses put a heavy financial strain on patients and healthcare systems, especially in nations where insurance may not be enough to pay for such cutting-edge treatments. Moreover, patients receiving LVAD implantation need continuous follow-up care for life, involving routine check-ups and constant monitoring, which heightens the financial obligation. Even with improvements in payment methods and insurance plans, the steep cost continues to hinder broader LVAD use, restricting access for numerous patients who require it.
UAE Left Ventricular Assist Devices Market Trend:
Hybrid LVAD-Heart Transplant Methods Gaining Momentum – A notable trend in the UAE's LVAD market is the increasing use of hybrid LVAD-heart transplant methods, which integrate LVAD technology with heart transplant operations. This approach is gaining more popularity in situations where patients are not ready for a heart transplant but need either short-term or long-term circulatory assistance. Hybrid strategies enable patients to obtain LVAD as a temporary solution before a heart transplant, aiding in the stabilization of their condition while they wait for a donor's heart. Utilizing LVADs as transitional support for transplantation markedly enhances survival rates, with over 80% of patients relying on LVADs for this purpose surviving until a donor's heart becomes accessible. Moreover, hybrid methods offer a chance to address the increasing disparity between the quantity of accessible donor hearts and the count of patients requiring them, thus enhancing patient results and survival statistics. This trend is anticipated to increase with improvements in LVAD technology and transplant management.
UAE Left Ventricular Assist Devices (LVADs) Market (2025-30): Segmentation Analysis
The UAE Left Ventricular Assist Devices (LVADs) Market study of MarkNtel Advisors evaluates & highlights the major trends and influencing factors in each segment. It includes predictions for the period 2025–2030 at the national level. Based on the analysis, the market has been further classified as:
Based on the Type of Flow:
- Pulsatile Flow
- Non-Pulsatile Flow
The Non-Pulsatile flow segment currently leads the UAE LVADs market, representing more than 70% of the market share. Non-Pulsatile LVADs are preferred over pulsatile flow devices because of their greater reliability, smaller dimensions, and better patient outcomes. These devices provide more stable and effective blood circulation, lowering the chances of issues such as device malfunction or thrombosis, thus making them better for prolonged use. Furthermore, Non-pulsatile LVADs are more convenient, offering patients a greater degree of comfort and mobility, essential for those requiring long-term support. The increasing appeal of these devices is further driven by technological progress, making Non-Pulsatile flow systems more affordable and accessible. Consequently, Non-Pulsatile LVADs are projected to retain their leading position in the UAE market.
Based on Application:
- Bridge to Transplantation
- Destination Therapy
- Bridge to Recovery
- Bridge to Candidacy
The Bridge to Transplantation segment is the leading application in the UAE LVADs market holding up to 75% of the market share. This approach is used for patients with advanced heart failure who are awaiting a heart transplant. LVADs in BTT applications provide crucial short-term circulatory support to stabilize patients until a suitable donor heart becomes available. Given the growing shortage of donor organs and the increasing prevalence of heart failure, BTT has become a vital solution in managing patients on the transplant list. In the UAE, heart transplant programs are expanding, and BTT is commonly used in hospitals such as Cleveland Clinic Abu Dhabi, which is equipped with advanced cardiac care facilities. The demand for BTT is expected to rise as heart failure rates increase and more patients require urgent heart transplants. As a result, the Bridge to Transplantation segment remains dominant in the market, addressing the critical need for heart transplant support.
UAE Left Ventricular Assist Devices (LVADs) Industry Recent Development:
- August 2024: Abbott and Cadrenal Therapeutics are exploring a collaboration on a pivotal study to assess tecarfarin's safety and efficacy in preventing blood clots in patients with newly implanted LVADs, aiming to improve anticoagulation treatment.
Gain a Competitive Edge with Our UAE Left Ventricular Assist Devices (LVADs) Market Report
- The UAE Left Ventricular Assist Devices (LVADs) Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & market share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of market dynamics & make informed decisions.
- This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
- The UAE Left Ventricular Assist Devices (LVADs) Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.
*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.
Frequently Asked Questions
- Market Segmentation
- Introduction
- Product Definition
- Research Process
- Assumptions
- Executive Summary
- UAE Left Ventricular Assist Devices (LVADs) Market Trends & Developments
- UAE Left Ventricular Assist Devices (LVADs) Market Start-up Ecosystem
- Entrepreneurial Activity
- Funding Received by Top Companies
- Key Investors Active in the Market
- Series-wise Funding Received
- Seed Funding
- Angel Investing
- Venture Capitalists (VC) Funding
- Others
- UAE Left Ventricular Assist Devices (LVADs) Market Industry Dynamics
- Growth Drivers
- Challenges
- UAE Left Ventricular Assist Devices (LVADs) Market Opportunities & Hotspots
- UAE Left Ventricular Assist Devices (LVADs) Market Value Chain Analysis
- UAE Left Ventricular Assist Devices (LVADs) Market Regulations and Policy
- UAE Left Ventricular Assist Devices (LVADs) Market Outlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Type of Flow
- Pulsatile Flow - Market Size & Forecast 2020-2030, USD Million
- Non-Pulsatile Flow - Market Size & Forecast 2020-2030, USD Million
- By Design
- Implantable Ventricular Assist Devices - Market Size & Forecast 2020-2030, USD Million
- Transcutaneous Ventricular Assist Devices - Market Size & Forecast 2020-2030, USD Million
- By Application
- Bridge to Transplantation - Market Size & Forecast 2020-2030, USD Million
- Destination Therapy - Market Size & Forecast 2020-2030, USD Million
- Bridge to Recovery - Market Size & Forecast 2020-2030, USD Million
- Bridge to Candidacy - Market Size & Forecast 2020-2030, USD Million
- By Region
- Dubai
- Abu Dhabi
- Sharjah
- Northern Emirates
- By Company
- Competition Characteristics
- Market Share & Analysis
- By Type of Flow
- Market Size & Analysis
- UAE Pulsatile Flow Left Ventricular Assist Devices (LVADs) Market Outlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Design - Market Size & Forecast 2020-2030, USD Million
- By Application - Market Size & Forecast 2020-2030, USD Million
- By Region-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- UAE Non-Pulsatile Flow Left Ventricular Assist Devices (LVADs) Market Outlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Design - Market Size & Forecast 2020-2030, USD Million
- By Application - Market Size & Forecast 2020-2030, USD Million
- By Region-Market Size & Forecast 2020-2030, USD Million
- Market Size & Analysis
- UAE Left Ventricular Assist Devices (LVADs) Market Strategic Imperatives for Growth & Success
- Competition Outlook
- Abbott Laboratories
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Cadrenal Therapeutics
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Fresenius Medical Care AG & Co. KGaA
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Abiomed Inc.
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Teleflex Incorporated
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- SynCardia Systems
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- CardiacAssist, Inc.
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Jarvik 2000
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Reliant Heart
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Edwards Lifesciences
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- GE Healthcare
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Others
- Abbott Laboratories
- Disclaimer
